Volume 144, Issue 5, Pages e4 (May 2013)

Slides:



Advertisements
Similar presentations
Alpha-Actinin 4 Is Associated with Cancer Cell Motility and Is a Potential Biomarker in Non–Small Cell Lung Cancer  Ming-Chuan Wang, PhD, Ying-Hua Chang,
Advertisements

Aldehyde Dehydrogenase 1A1 Possesses Stem-Like Properties and Predicts Lung Cancer Patient Outcome  Xiao Li, MD, Liyan Wan, MD, Jian Geng, MD, Chin-Lee.
Overexpression of CRM1: A Characteristic Feature in a Transformed Phenotype of Lung Carcinogenesis and a Molecular Target for Lung Cancer Adjuvant Therapy 
Volume 141, Issue 5, Pages e1 (November 2011)
INHBA Overexpression Promotes Cell Proliferation and May Be Epigenetically Regulated in Esophageal Adenocarcinoma  Christopher W. Seder, MD, Wibisono.
Silencing NKD2 by Promoter Region Hypermethylation Promotes Esophageal Cancer Progression by Activating Wnt Signaling  Baoping Cao, MD, PhD, Weili Yang,
Volume 146, Issue 5, Pages (May 2014)
Volume 144, Issue 3, Pages e1 (March 2013)
MicroRNA-30b is a multifunctional regulator of aortic valve interstitial cells  Mi Zhang, MD, Xiaohong Liu, MD, Xiwu Zhang, MD, Zhigang Song, MD, Lin Han,
Volume 144, Issue 5, Pages e10 (May 2013)
WT1 Promotes Invasion of NSCLC via Suppression of CDH1
Volume 143, Issue 3, Pages e2 (September 2012)
Volume 140, Issue 2, Pages e2 (February 2011)
Microsomal Prostaglandin E Synthase-1 Inhibits PTEN and Promotes Experimental Cholangiocarcinogenesis and Tumor Progression  Dongdong Lu, Chang Han, Tong.
Deregulation of SLIT2-Mediated Cdc42 Activity Is Associated with Esophageal Cancer Metastasis and Poor Prognosis  Ruo-Chia Tseng, PhD, Jia-Ming Chang,
Volume 135, Issue 5, Pages e2 (November 2008)
Volume 135, Issue 5, Pages e24 (November 2008)
Bongyong Lee, Joseph Mazar, Muhammad N
Volume 131, Issue 3, Pages (September 2006)
INHBA Overexpression Promotes Cell Proliferation and May Be Epigenetically Regulated in Esophageal Adenocarcinoma  Christopher W. Seder, MD, Wibisono.
Volume 138, Issue 5, Pages e4 (May 2010)
Volume 136, Issue 2, Pages e1 (February 2009)
Volume 137, Issue 2, Pages e2 (August 2009)
Volume 141, Issue 5, Pages e1 (November 2011)
Volume 138, Issue 3, Pages e2 (March 2010)
Volume 131, Issue 3, Pages (September 2006)
This Month in Gastroenterology
Volume 136, Issue 5, Pages (May 2009)
Brahma-related gene 1 inhibits proliferation and migration of human aortic smooth muscle cells by directly up-regulating Ras-related associated with diabetes.
TGM2: A Cell Surface Marker in Esophageal Adenocarcinomas
Verena N. Lorenz, Michael P. Schön, Cornelia S. Seitz 
Volume 146, Issue 7, Pages e5 (June 2014)
Volume 142, Issue 4, Pages e12 (April 2012)
Volume 139, Issue 6, Pages (December 2010)
Volume 19, Issue 2, Pages (February 2017)
Volume 129, Issue 1, Pages (July 2005)
Volume 150, Issue 1, Pages e4 (January 2016)
Volume 134, Issue 1, Pages (January 2008)
Volume 140, Issue 1, Pages e2 (January 2011)
Aldehyde Dehydrogenase 1A1 Possesses Stem-Like Properties and Predicts Lung Cancer Patient Outcome  Xiao Li, MD, Liyan Wan, MD, Jian Geng, MD, Chin-Lee.
Volume 144, Issue 5, Pages e1 (May 2013)
Volume 145, Issue 2, Pages e6 (August 2013)
Alpha-Actinin 4 Is Associated with Cancer Cell Motility and Is a Potential Biomarker in Non–Small Cell Lung Cancer  Ming-Chuan Wang, PhD, Ying-Hua Chang,
Glyoxalase I Is Differentially Expressed in Cutaneous Neoplasms and Contributes to the Progression of Squamous Cell Carcinoma  Xiao-Yan Zou, Dong Ding,
Volume 129, Issue 3, Pages (September 2005)
Volume 133, Issue 1, Pages (July 2007)
Volume 136, Issue 2, Pages (February 2009)
Volume 146, Issue 5, Pages (May 2014)
Volume 138, Issue 2, Pages e2 (February 2010)
Volume 143, Issue 6, Pages e5 (December 2012)
Volume 141, Issue 6, Pages e5 (December 2011)
Volume 155, Issue 3, Pages e3 (September 2018)
Molecular Therapy - Nucleic Acids
Volume 132, Issue 7, Pages (June 2007)
MicroRNA-101 Exerts Tumor-Suppressive Functions in Non-small Cell Lung Cancer through Directly Targeting Enhancer of Zeste Homolog 2  Ji-guang Zhang,
Volume 142, Issue 7, Pages e2 (June 2012)
This Month in Gastroenterology
Volume 137, Issue 1, Pages (July 2009)
Integrative Functional Genomics Implicates EPB41 Dysregulation in Hepatocellular Carcinoma Risk  Xinyu Yang, Dianke Yu, Yanli Ren, Jinyu Wei, Wenting.
Microsomal Prostaglandin E Synthase-1 Inhibits PTEN and Promotes Experimental Cholangiocarcinogenesis and Tumor Progression  Dongdong Lu, Chang Han, Tong.
Volume 137, Issue 6, Pages e5 (December 2009)
Yabin Cheng, Guangdi Chen, Magdalena Martinka, Vincent Ho, Gang Li 
Volume 132, Issue 4, Pages (April 2007)
Epigenetic Silencing of SPINT2 Promotes Cancer Cell Motility via HGF-MET Pathway Activation in Melanoma  Soonyean Hwang, Hye-Eun Kim, Michelle Min, Rekha.
Volume 141, Issue 3, Pages (September 2011)
Volume 142, Issue 4, Pages e4 (April 2012)
Volume 134, Issue 1, Pages (January 2008)
Long Noncoding RNA BC as a Novel Therapeutic Target for Colorectal Cancer that Suppresses Metastasis by Upregulating TIMP3  Jiaxin Lin, Xin Tan,
Volume 131, Issue 6, Pages (December 2006)
Overexpression of CRM1: A Characteristic Feature in a Transformed Phenotype of Lung Carcinogenesis and a Molecular Target for Lung Cancer Adjuvant Therapy 
Presentation transcript:

Volume 144, Issue 5, Pages 956-966.e4 (May 2013) Hypomethylation of Noncoding DNA Regions and Overexpression of the Long Noncoding RNA, AFAP1-AS1, in Barrett's Esophagus and Esophageal Adenocarcinoma  Wenjing Wu, Tushar D. Bhagat, Xue Yang, Jee Hoon Song, Yulan Cheng, Rachana Agarwal, John M. Abraham, Sariat Ibrahim, Matthias Bartenstein, Zulfiqar Hussain, Masako Suzuki, Yiting Yu, Wei Chen, Charis Eng, John Greally, Amit Verma, Stephen J. Meltzer  Gastroenterology  Volume 144, Issue 5, Pages 956-966.e4 (May 2013) DOI: 10.1053/j.gastro.2013.01.019 Copyright © 2013 AGA Institute Terms and Conditions

Figure 1 Genome-wide hypomethylation in BE. (A) Three sets of endoscopic biopsy specimens representing NE and BE were examined using HELP tagging. Hypomethylation was seen in BE (t test, **P < .005; *P < .05). Hierarchical clustering was based on CpG methylation for all (B) probes, (C) coding regions, and (D) noncoding regions. Correlation plots were created based on methylation of (E) coding and (F) noncoding regions. Gastroenterology 2013 144, 956-966.e4DOI: (10.1053/j.gastro.2013.01.019) Copyright © 2013 AGA Institute Terms and Conditions

Figure 2 Hypomethylation affects noncoding regions. (A and B) Volcano plots display differences in mean methylation between NE and BE samples (x-axis) and logs of P values between means (y-axis). Differentially methylated loci (red) reveal hypomethylation in both large and small noncoding regions. (C) Heat map displaying differential CpG methylation at all noncoding regions shows predominant hypomethylation. (D) Bar graph illustrating distribution of CpG densities according to differential methylation. Gastroenterology 2013 144, 956-966.e4DOI: (10.1053/j.gastro.2013.01.019) Copyright © 2013 AGA Institute Terms and Conditions

Figure 3 Aberrant methylation and expression of AFAP1-AS1 in human EAC. (A) HELP-tagging results for matched BE and NE samples. Upward vertical bars (proportional to percent hypomethylation) are taller and more numerous in BE1 than in NE1, showing relative hypomethylation at the AFAP1-AS1 locus in BE. (B) Expression of AFAP1-AS1 (upper panel) and AFAP1 (lower panel) in tissues studied for methylation. AFAP1-AS1 expression was significantly higher in BE than NE in 2 of the 3 tissue pairs. AFAP1 expression was lower than AFAP1-AS1 expression but not significantly different between BE and NE. (C) Bisulfite MassArray analysis of methylation of the AFAP1-AS1 locus reveals hypomethylation in sample B1 (BE) relative to its matched N1 (NE) sample. Normal stomach (NS) is methylated similarly to NE. Sample B3 is not hypomethylated compared with N3, in agreement with expression levels for this paired set. (D) AFAP1-AS1 expression was elevated in all EAC cell lines tested (OE33, SKGT4, FLO-1). HEEpic, nonimmortalized normal primary esophageal epithelial cells. * P<.05 compared with HEEpic. (E) In 20 EAC cases, AFAP1-AS1 expression was elevated in 75% of EACs (15/20) versus NE tissues. AFAP1-AS1 expression was elevated in 91% of BEs (11/12) relative to NE tissues. (F) Expression levels of AFAP1 in NE and EAC tissues from 20 patients. There was no significant difference between NE and EAC. Gastroenterology 2013 144, 956-966.e4DOI: (10.1053/j.gastro.2013.01.019) Copyright © 2013 AGA Institute Terms and Conditions

Figure 4 Knockdown efficiency of AFAP1-AS1–specific siRNAs in EAC cells. (A and B) Two siRNA molecules were tested. Both siRNAs at 20 nmol/L and 60 nmol/L yielded ≥60% reduced expression of AFAP1-AS1 in OE33 and SKGT4 EAC cells (vs scrambled siRNAs). * P<.05. Gastroenterology 2013 144, 956-966.e4DOI: (10.1053/j.gastro.2013.01.019) Copyright © 2013 AGA Institute Terms and Conditions

Figure 5 Inhibition of AFAP1-AS1 significantly reduces proliferation and colony formation in EAC cells. (A) WST-1 cell proliferation assays in OE33 and SKGT4 cells. Both the 20 nmol/L and 60 nmol/L concentrations induced significantly lower growth rates *(P < .01 and *P < .01, respectively). (B) Colony formation assays. (Left panel) AFAP1-AS1–specific siRNA-treated cells (2 wells at right) versus scrambled control siRNA-treated cells (leftmost well) (original magnification 10×). (Right panel) Mean ± standard deviation of 3 independent experiments. **P < .05. (C) Relative to treatment with a scrambled siRNA, transfection with a specific AFAP1-AS1 siRNA induced significant apoptosis (lower right quadrant, 23.76% ± 1.50% vs 7.63% ± 2.62%; *P < .05) in OE33 cells. (D) Western blotting revealed cleaved caspase-3 only in AFAP1-AS1 siRNA-treated cells. (E) Cell cycle results in OE33 EAC cells. Relative to treatment with a scrambled siRNA, transfection with a specific AFAP1-AS1 siRNA induced significant G2/M-phase cell cycle arrest. *P<.05. NSC, nonspecific control siRNA. Gastroenterology 2013 144, 956-966.e4DOI: (10.1053/j.gastro.2013.01.019) Copyright © 2013 AGA Institute Terms and Conditions

Figure 6 AFAP1-AS1 suppression inhibits cell motility. (A) Wound healing assays. AFAP1-AS1 suppression by siRNA decreased SKGT4 cell motility (original magnification 10×). (B) In vitro migration and invasion assays. *P < .05. NSC, nonspecific control siRNA. Gastroenterology 2013 144, 956-966.e4DOI: (10.1053/j.gastro.2013.01.019) Copyright © 2013 AGA Institute Terms and Conditions

Supplementary Figure 2 Expression levels of AFAP1-AS1 and AFAP1 are compared in matching normal esophagus, BE, and EAC from the same 3 patients. (A) Two of these patients exhibit higher RNA levels of both AFAP1-AS1 and AFAP1 in BE and EAC versus NE, while the third patient shows no significant change in either of these RNAs. (B) AFAP1 protein levels in tissues from patient 1 (N, normal esophagus; B, Barrett's; T, EAC). Gastroenterology 2013 144, 956-966.e4DOI: (10.1053/j.gastro.2013.01.019) Copyright © 2013 AGA Institute Terms and Conditions

Supplementary Figure 3 HELP tagging results for matched BE and NE samples. Upward vertical bars, indicating percent hypomethylation, are taller and more numerous in BE at the AFAP1-AS1 locus (red box), thus showing relative hypomethylation at this noncoding locus. The methylation profile at the start site of the AFAP1 gene is very similar between NE and BE (blue box). Gastroenterology 2013 144, 956-966.e4DOI: (10.1053/j.gastro.2013.01.019) Copyright © 2013 AGA Institute Terms and Conditions

Supplementary Figure 4 AFAP1 expression does not change significantly after AFAP1-AS1–specific siRNA transfection. (A and B) AFAP1 expression measured by quantitative reverse-transcription polymerase chain reaction 48 hours (left panel) and Western blot 72 hours (right panel) after AFAP1-AS1–specific siRNA treatment in SKGT4 and OE33 EAC cell lines, respectively. Although siRNA-1 affected AFAP1 expression, the magnitude of this effect was not significant. NSC, nonspecific control siRNA. Gastroenterology 2013 144, 956-966.e4DOI: (10.1053/j.gastro.2013.01.019) Copyright © 2013 AGA Institute Terms and Conditions

Supplementary Figure 5 Wound healing assays show that suppression of AFAP1-AS1 expression by siRNA results in decreased motility of OE33 cells. Moreover, when OE33 cells were treated with AFAP1-AS1-specific siRNA, cell death increased markedly within 24 hours. Images are representative of 3 independent experiments (magnification 10x). Gastroenterology 2013 144, 956-966.e4DOI: (10.1053/j.gastro.2013.01.019) Copyright © 2013 AGA Institute Terms and Conditions